| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $294,528,845 ) (Continued on the next page) |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01HL168383 | Role of CEBPb in flow-dependent endothelial dysfunction and atherosclerosis | 000 | 3 | NIH | 2/14/2025 | $674,409 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01AG075444 | Subtype-selective NMDA ligands for Alzheimer's Disease | 001 | 4 | NIH | 6/18/2025 | $62,207 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01AG075444 | Subtype-selective NMDA ligands for Alzheimer's Disease | 000 | 4 | NIH | 3/11/2025 | $699,842 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01NS047357 | Development of Synaptic Inputs on Spinal Interneurons | 000 | 18 | NIH | 3/11/2025 | $413,817 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01ES035738 | The Omics and Mixtures Integration on Traffic exposure and Preterm Birth (OMIT-PTB) Study | 000 | 2 | NIH | 3/4/2025 | $654,756 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R21AG083414 | HomePal: Developing a Smart Speaker-Based System for In-Home Loneliness Assessment for Older Adults | 005 | 4 | NIH | 6/3/2025 | $186,767 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | F31HD108974 | Developmental regulation of histone genes by pioneer factors and three-dimensional architecture | 001 | 3 | NIH | 6/17/2025 | $564 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01AI190202 | Metabolic and epigenetic regulation of skin Tregs | 000 | 1 | NIH | 2/25/2025 | $597,542 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | F31HD108974 | Developmental regulation of histone genes by pioneer factors and three-dimensional architecture | 000 | 3 | NIH | 2/14/2025 | $48,974 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01NS126392 | SCN8A encephalopathy: disease mechanisms and treatment | 000 | 3 | NIH | 2/14/2025 | $470,230 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01AI141327 | Structural and Chemical Analysis of Highly Potent ALLINI Platform | 002 | 7 | NIH | 5/13/2025 | $459,314 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01DK139326 | Comprehensive Assistance and Resources for Effective Diabetic Foot Navigation (CARE-D-Foot-Nav), a randomized controlled trial | 000 | 1 | NIH | 2/25/2025 | $555,034 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R00HL177821 | Investigating fibrinogen as a pathologic and targetable mediator of COVID-19-associated coagulopathy | 000 | 1 | NIH | 3/1/2025 | $391,250 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01MH134972 | Superior Colliculus Pathways for Defensive Behavior and Emotional Arousal | 000 | 2 | NIH | 2/14/2025 | $582,354 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | F31NR020848 | The Influence of Symptoms, Functional Status, and Geographic Factors on Healthcare Use Among Patients Receiving Dialysis | 001 | 2 | NIH | 6/3/2025 | $564 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | F31NR020848 | The Influence of Symptoms, Functional Status, and Geographic Factors on Healthcare Use Among Patients Receiving Dialysis | 000 | 2 | NIH | 2/14/2025 | $48,974 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | F31CA281258 | Mechanism underlying how host B cells empower adoptively transferred Th17 cells with durable tumor immunity | 000 | 2 | NIH | 3/3/2025 | $48,974 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01NR019083 | Prevention of Pediatric NAFLD in Hispanic Children | 001 | 5 | NIH | 2/14/2025 | $514,265 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01NR019083 | Prevention of Pediatric NAFLD in Hispanic Children | 002 | 5 | NIH | 4/11/2025 | $57,141 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01CA198279 | Shaping DNA Damage Response Networks Via Histone H2A Variants | 005 | 9 | NIH | 5/26/2025 | $37,819 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01CA198279 | Shaping DNA Damage Response Networks Via Histone H2A Variants | 002 | 9 | NIH | 4/25/2025 | $340,375 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | F31CA281258 | Mechanism underlying how host B cells empower adoptively transferred Th17 cells with durable tumor immunity | 001 | 2 | NIH | 5/22/2025 | $564 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R00HL161355 | Accumulation of stress and trauma across the life course and cardiometabolic risk during pregnancy and postpartum | 000 | 4 | NIH | 2/27/2025 | $248,971 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01AI173946 | Cavity and Granuloma Oriented Inflammation and Tissue Pharmacokinetics in Pulmonary Tuberculosis (COOK TB) | 000 | 3 | NIH | 2/13/2025 | $762,816 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01CA258857 | Targeting posttranslational modifications of CD73 in TNBCs | 001 | 5 | NIH | 5/23/2025 | $64,474 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01CA258857 | Targeting posttranslational modifications of CD73 in TNBCs | 000 | 5 | NIH | 3/14/2025 | $580,272 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | U2RTW010114 | 2/2 – Regional GEOHealth Hub Centered in Peru-U.S. | 000 | 9 | NIH | 2/24/2025 | $1 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | U2RTW010114 | 2/2 – Regional GEOHealth Hub Centered in Peru-U.S. | 000 | 9 | NIH | 2/24/2025 | $1 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | U2RTW010114 | 2/2 – Regional GEOHealth Hub Centered in Peru-U.S. | 000 | 9 | NIH | 2/24/2025 | $299,961 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | K01ES035082 | Cumulative effects of persistent organic pollutants and non-chemical stressors on child development | 000 | 2 | NIH | 3/4/2025 | $160,243 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | K23NS119964 | Identifying Pathophysiological Signatures of DLB Cognitive and Neuropsychiatric Decline Using a Systems-Based Proteomic Approach | 000 | 4 | NIH | 2/13/2025 | $195,156 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R21AI178324 | Multiomics Characterization of Micobiome and Immunometabolic REmodeling in Tuberculosis Stress Hyperglycemia | 000 | 2 | NIH | 2/13/2025 | $227,708 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | F31MH132407 | Adaptation of a PrEP Shared-Decision Making Tool for Family Planning Clinics | 000 | 3 | NIH | 3/20/2025 | $48,994 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01ES037289 | New Statistical Methods for Estimating Health Effects of Environmental Exposures | 000 | 1 | NIH | 6/17/2025 | $599,416 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01EY033361 | Mechanisms of axial elongation in myopia | 000 | 4 | NIH | 3/19/2025 | $559,114 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01DK136023 | Developing statistical analysis and prediction tools for continuous glucose monitoring (CGM) use in hospitalized patients with diabetes | 001 | 2 | NIH | 6/13/2025 | $37,072 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01DK136023 | Developing statistical analysis and prediction tools for continuous glucose monitoring (CGM) use in hospitalized patients with diabetes | 000 | 2 | NIH | 2/25/2025 | $333,644 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01NS125768 | A Conserved RNA Binding Protein Required for Control of Key Developmental Pathways | 000 | 4 | NIH | 2/20/2025 | $342,235 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | D43TW012459 | Training on ImplemenTAtioN and team Science for NCD Control (TITANS) program | 000 | 3 | NIH | 2/20/2025 | $248,400 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | F31AR081697 | Toward therapeutic targeting of liquid-liquid phase separation dynamics in skin | 000 | 3 | NIH | 3/18/2025 | $48,974 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R00HD104991 | Placental and breastmilk microRNAs in relation to early-life growth and metabolism | 001 | 4 | NIH | 4/14/2025 | $24,898 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R00HD104991 | Placental and breastmilk microRNAs in relation to early-life growth and metabolism | 000 | 4 | NIH | 2/19/2025 | $224,096 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01CA259192 | Improving our understanding of breast cancer mortality disparities through recurrence: a multi-level approach among women in Georgia | 001 | 5 | NIH | 4/25/2025 | $0 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01CA259192 | Improving our understanding of breast cancer mortality disparities through recurrence: a multi-level approach among women in Georgia | 000 | 5 | NIH | 3/5/2025 | $446,934 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | T32EB035514 | Advancement of Diagnostics by Joining User-centered and Scalable Technologies - Training Program (ADJUST TP) | 000 | 1 | NIH | 5/26/2025 | $108,384 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01AT011990 | Development and validation of a high-throughput MicroED-driven platform technology for natural product discovery | 000 | 4 | NIH | 3/17/2025 | $161,387 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01AT011990 | Development and validation of a high-throughput MicroED-driven platform technology for natural product discovery | 000 | 4 | NIH | 3/17/2025 | $393,703 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R35HL145000 | Engineering biophysical microtechnologies for hematologic applications in health and disease | 000 | 7 | NIH | 3/17/2025 | $697,684 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | F31DA059435 | Epitranscriptomic mechanisms of the antidepressant response to ketamine in human neurons | 000 | 3 | NIH | 3/17/2025 | $48,974 |
|
